Pushkal Garg, EVP Chief R&D: Alnylam Pharmaceuticals ALNY Sell · Filed 25/08/19

Trade details

Type: Insider sale
Amount: $246,543.72
Shares · price: 543 sh · $454.04 a share
Held after: 21,929 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Pushkal GargEVP Chief R&D
Trade date: 25/08/18
Filed: 25/08/19
Days to filing: 1 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Pushkal Garg's recent trades

Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$248.4K
767 sh
$248.4K
Filed 03/06
Traded 03/04
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$239.4K
740 sh
$239.4K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$210.8K
654 sh
$210.8K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$165.5K
510 sh
$165.5K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$163K
500 sh
$163K
Filed 03/06
Traded 03/05

Pushkal Garg, Chief Officer — sold $246.5K of Alnylam Pharmaceuticals ALNY · 2.4% of holdings · 10b5-1 plan | Whalegun